Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Humphreys

Showing results (111-120 of 272) with videos related to

Pageof 28
Sort By:
Journal of the American Chemical Society|February 29, 2008
Total synthesis of the strychnos alkaloid (+)-minfiensine: tandem enantioselective intramolecular Heck-iminium ion cyclizationAmy B Dounay, Philip G Humphreys, Larry E Overman, et al.
Journal of Experimental Psychology. General|January 29, 2000
Systematic analysis of deficits in visual attentionJ Duncan, C Bundesen, A Olson, et al.
European Journal of Pharmacology|November 9, 2000
Desipramine changes salivary gland function, oral microbiota, and oral health in ratsM M Koller, N Maeda, P J Scarpace, et al.
Clinical Immunology and Immunopathology|April 1, 1996
Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: a potential trigger for sialoadenitis of NOD miceC P Robinson, H Yamamoto, A B Peck, et al.
Synapse (New York, N.Y.)|August 15, 1998
Parallel nature of hippocampal synaptic plasticityD A Young, A G Humphreys, D A Engstrom, et al.
Drug Discovery Today|September 8, 2024
Collaborative GSK-University of Strathclyde doctoral research and training programmes: Transforming approaches to industry-academia engagementLaura C Paterson, Philip G Humphreys, Henry A Kelly, et al.
Archives of Oral Biology|January 1, 1991
Regulation of cell-surface galactosyltransferase in isoproterenol-treated mouse parotid glandsN Maeda, K R Purushotham, M M Koller, et al.
British Journal of Clinical Pharmacology|February 23, 2018
Physiologically-based pharmacokinetic modelling of a CYP2C19 substrate, BMS-823778, utilizing pharmacogenetic dataJiachang Gong, Lisa Iacono, Ramaswamy A Iyer, et al.
Current Opinion in Chemical Biology|June 14, 2016
Clinical progress and pharmacology of small molecule bromodomain inhibitorsNatalie H Theodoulou, Nicholas Co Tomkinson, Rab K Prinjha, et al.
Microbiology and Immunology|January 1, 1997
Effects of chronic isoproterenol treatment or submandibular and sublingual ablation on microflora of mouse tooth surfacesN Maeda, M Okamoto, Y Nakagawa, et al.
Pageof 28

Showing results (111-120 of 272) with videos related to

Sort By:
Pageof 28
Journal of the American Chemical Society|February 29, 2008
Total synthesis of the strychnos alkaloid (+)-minfiensine: tandem enantioselective intramolecular Heck-iminium ion cyclizationAmy B Dounay, Philip G Humphreys, Larry E Overman, et al.
Journal of Experimental Psychology. General|January 29, 2000
Systematic analysis of deficits in visual attentionJ Duncan, C Bundesen, A Olson, et al.
European Journal of Pharmacology|November 9, 2000
Desipramine changes salivary gland function, oral microbiota, and oral health in ratsM M Koller, N Maeda, P J Scarpace, et al.
Clinical Immunology and Immunopathology|April 1, 1996
Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: a potential trigger for sialoadenitis of NOD miceC P Robinson, H Yamamoto, A B Peck, et al.
Synapse (New York, N.Y.)|August 15, 1998
Parallel nature of hippocampal synaptic plasticityD A Young, A G Humphreys, D A Engstrom, et al.
Drug Discovery Today|September 8, 2024
Collaborative GSK-University of Strathclyde doctoral research and training programmes: Transforming approaches to industry-academia engagementLaura C Paterson, Philip G Humphreys, Henry A Kelly, et al.
Archives of Oral Biology|January 1, 1991
Regulation of cell-surface galactosyltransferase in isoproterenol-treated mouse parotid glandsN Maeda, K R Purushotham, M M Koller, et al.
British Journal of Clinical Pharmacology|February 23, 2018
Physiologically-based pharmacokinetic modelling of a CYP2C19 substrate, BMS-823778, utilizing pharmacogenetic dataJiachang Gong, Lisa Iacono, Ramaswamy A Iyer, et al.
Current Opinion in Chemical Biology|June 14, 2016
Clinical progress and pharmacology of small molecule bromodomain inhibitorsNatalie H Theodoulou, Nicholas Co Tomkinson, Rab K Prinjha, et al.
Microbiology and Immunology|January 1, 1997
Effects of chronic isoproterenol treatment or submandibular and sublingual ablation on microflora of mouse tooth surfacesN Maeda, M Okamoto, Y Nakagawa, et al.
Pageof 28